Triple
T1445198
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Federal Food, Drug, and Cosmetic Act |
E31160
|
entity |
| Predicate | amendedBy |
P1121
|
FINISHED |
| Object |
Drug Price Competition and Patent Term Restoration Act of 1984
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
|
E165704
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Drug Price Competition and Patent Term Restoration Act of 1984 | Statement: [Federal Food, Drug, and Cosmetic Act, amendedBy, Drug Price Competition and Patent Term Restoration Act of 1984]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Drug Price Competition and Patent Term Restoration Act of 1984 Context triple: [Federal Food, Drug, and Cosmetic Act, amendedBy, Drug Price Competition and Patent Term Restoration Act of 1984]
-
A.
False Claims Amendments Act of 1986
The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
-
B.
Anti-Drug Abuse Act of 1988
The Anti-Drug Abuse Act of 1988 is a U.S. federal law that expanded the war on drugs by increasing penalties, funding enforcement and treatment programs, and establishing a coordinated national drug control strategy.
-
C.
Anti-Drug Abuse Act of 1986
The Anti-Drug Abuse Act of 1986 is a major U.S. federal law that significantly escalated the War on Drugs by establishing mandatory minimum sentences and harsher penalties for drug offenses, particularly involving crack cocaine.
-
D.
Patent and Trademark Law Amendments Act
The Patent and Trademark Law Amendments Act, commonly known as the Bayh–Dole Act, is a U.S. federal law that allows universities, small businesses, and non-profits to retain ownership of inventions developed with federal funding, thereby promoting commercialization of research.
-
E.
Bayh–Dole Act
The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Drug Price Competition and Patent Term Restoration Act of 1984 Triple: [Federal Food, Drug, and Cosmetic Act, amendedBy, Drug Price Competition and Patent Term Restoration Act of 1984]
Generated description
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Drug Price Competition and Patent Term Restoration Act of 1984 Target entity description: The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
-
A.
False Claims Amendments Act of 1986
The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
-
B.
Anti-Drug Abuse Act of 1988
The Anti-Drug Abuse Act of 1988 is a U.S. federal law that expanded the war on drugs by increasing penalties, funding enforcement and treatment programs, and establishing a coordinated national drug control strategy.
-
C.
Anti-Drug Abuse Act of 1986
The Anti-Drug Abuse Act of 1986 is a major U.S. federal law that significantly escalated the War on Drugs by establishing mandatory minimum sentences and harsher penalties for drug offenses, particularly involving crack cocaine.
-
D.
Patent and Trademark Law Amendments Act
The Patent and Trademark Law Amendments Act, commonly known as the Bayh–Dole Act, is a U.S. federal law that allows universities, small businesses, and non-profits to retain ownership of inventions developed with federal funding, thereby promoting commercialization of research.
-
E.
Bayh–Dole Act
The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4991633388190a4d61b5a98aa407a |
completed | March 1, 2026, 7:52 p.m. |
| NER | Named-entity recognition | batch_69a4c55714588190a95b4f677c21cbaa |
completed | March 1, 2026, 11:01 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ad08c046b08190a448ba2549dc5e00 |
completed | March 8, 2026, 5:27 a.m. |
| NEDg | Description generation | batch_69ad09ec3b388190b492e8959a3617c9 |
completed | March 8, 2026, 5:32 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ad0aefb1c88190a368d68454a0b9d0 |
completed | March 8, 2026, 5:36 a.m. |
Created at: March 1, 2026, 8 p.m.